Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. COLLABORATION AND...Collaboration and License Agreement • October 14th, 2022 • Sesen Bio, Inc. • Pharmaceutical preparations • Delaware
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into and made effective as of January 7, 2022 (the “Effective Date”) by and among CARISMA Therapeutics Inc., a Delaware corporation (“Carisma”), and ModernaTX, Inc., a Delaware corporation (“Moderna”). Moderna and Carisma are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. LICENSE AGREEMENT DATED...License Agreement • October 14th, 2022 • Sesen Bio, Inc. • Pharmaceutical preparations • Pennsylvania
This License Agreement (this “Agreement”) is dated as of November 10, 2017 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and CARMA Therapeutics Inc., a Delaware corporation having a place of business at 3001 Market Street, Ste 140, Philadelphia, PA 19104 (“Licensee”). Penn and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.
LICENSE AGREEMENTLicense Agreement • October 14th, 2022 • Sesen Bio, Inc. • Pharmaceutical preparations • New York
NEW YORK UNIVERSITY (hereinafter “NYU”), a corporation organized and existing under the laws of the State of New York and having a place of business at 70 Washington Square South, New York, New York 10012;
